MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$142,623K
(9.64%↑ Y/Y)
Loss before equity in
net losses of joint...
-$142,623K
(8.75%↑ Y/Y)
Loss before income
taxes
-$141,608K
(9.30%↑ Y/Y)
Income tax expense
$1,015K
(511.45%↑ Y/Y)
Product
$73,551K
(6.16%↑ Y/Y)
License And Royalty
Revenue
$7,806K
Loss from operations
-$121,499K
(7.01%↑ Y/Y)
Total other expense,
net
-$20,109K
(21.09%↑ Y/Y)
Total revenue, net
$81,357K
(14.85%↑ Y/Y)
Other, net
$22,714K
(82.34%↑ Y/Y)
Interest income
$8,810K
(-28.21%↓ Y/Y)
Total operating
expense
$202,856K
(0.68%↑ Y/Y)
Interest expense
$51,633K
(2.83%↑ Y/Y)
Research and development
$104,005K
(-5.13%↓ Y/Y)
Selling and marketing
$43,374K
(-1.46%↓ Y/Y)
General and
administrative
$36,559K
(-12.73%↓ Y/Y)
Restructuring, impairment and
other related costs
$13,120K
Cost of product sales
$5,798K
(-2.54%↓ Y/Y)
Deferred royalty
obligation interest...
$35,346K
(5.17%↑ Y/Y)
Effective interest
expense on senior...
$16,275K
(-1.97%↓ Y/Y)
Other interest
expense
$12K
(1100.00%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT)